Pro Feature
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moATROPINE SULFATE (atropine sulfate) by Fresenius Kabi is muscarine-like actions of acetylcholine and other choline esters. Approved for older for: atropine is an anticholinergic indicated in adults, older for: cycloplegia (1. First approved in 2022.
Drug data last refreshed 18h ago
muscarine-like actions of acetylcholine and other choline esters. Atropine inhibits the muscarinic actions of acetylcholine on structures innervated by postganglionic cholinergic nerves, and on smooth muscles which respond to endogenous acetylcholine but are not so innervated. As with other…
Worked on ATROPINE SULFATE at Fresenius Kabi? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
A Study of Atropine Sulfate in Healthy Chinese Volunteers
A Phase III Clinical Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops
A Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo